Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia

Diabetic Medicine

Volumn 20, Issue 12, 2003, Pages 1027-1033

  Qiao, Qing ^a   Lindstrom J ^a   Valle, T T ^a   Tuomilehto, J ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Area under ROC curve; Hazard ratio; Impaired fasting glycemia; Impaired glucose tolerance; Incidence of diabetes; Risk predictor; ROC curve

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; RISK ASSESSMENT; ROC CURVE; AGE DISTRIBUTION; AREA UNDER THE CURVE; BLOOD; BODY CONSTITUTION; DIET RESTRICTION; DISEASE COURSE; GLUCOSE TOLERANCE TEST; INCIDENCE; MIDDLE AGED; PHYSIOLOGY; PREVALENCE; PROGNOSIS; RISK FACTOR; SEX RATIO;

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGE DISTRIBUTION; AREA UNDER CURVE; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS; DISEASE PROGRESSION; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION;

EID: 1542544608     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2003.01054.x     Document Type: Article

References (23)

1. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991; 34: 891-898.
2. Pan X, Li G, Hu Y, Wang J, Yang W, An Z et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
4. Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
5. Chiasson J, Gomis R, Hanefeld M, Josse R, Karasik A, Laakso M. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care 1998; 21: 1720-1725.
6. Yang W, Lin L, Qi J, Yu Z, Pei H, He G et al. The preventive effect of acarbose and metformin on the progression to diabetes mellitus in the IGT population: a 3-year multicenter prospective study. Clin J Endocrinol Metab 2001; 17: 131-135.
7. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
8. DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999; 354: 617-621.
9. DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
10. Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002; 23: 1267-1275.
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
12. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation; 1999 Report no. 99.2.
13. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
14. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 1999; 22: 399-402.
15. Vaccaro O, Ruffa G, Imperatore G, lovino V, Rivellese A, Riccardi G. Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care 1999; 22: 1490-1493.
16. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000; 23: 1108-1112.
17. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001; 285: 2109-2113.
18. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994; 309: 23-27.
19. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol 1994; 23: 495-504.
20. Tuomilehto J, Korhonen HJ, Kartovaara L, Salomaa V, Stengard JH, Pitkanen M et al. Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 1991; 20: 1010-1017.
21. Fletcher R, Fletcher S, Wagner E. (eds) Clinical Epidemiology, the Essentials, 2nd edn. Baltimore: Williams & Wilkins, 1988.
22. Dinneen SF, Maldonado D, Leibson CL, Klee GG, Li H, Melton LJ et al. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 1998; 21: 1408-1413.
23. Troisi RJ, Cowie CC, Harris MI. Diurnal variation in fasting plasma glucose, implications for diagnosis of diabetes in patients examined in the afternoon. JAMA 2000; 284: 3157-3159.